Rare Diseases
Latest News
High early recurrence rates with Merkel cell carcinoma
Approximately 95% of all recurrences happened within 3 years of the initial diagnosis in the prospective cohort study.
Rare Diseases Report 2021
Adaptive therapy borrows from nature to keep rhabdomyosarcoma in check
Researchers are applying evolutionary principles to the treatment of childhood, fusion-positive rhabdomyosarcoma.
Rare Diseases Report 2021
Mesothelioma trials: Moving toward improved survival
Latest News
Genomic screening of healthy newborns gets more popular
For now, the findings on the psychosocial effects of general newborn genomic screening show that “we should consider genetics to be just one more...
Conference Coverage
Validity of commercial serologic tests for dermatomyositis still questionable
“The testing in research laboratories is not widely available and the results are often delayed by weeks to months.”
News
FDA approves new interferon for polycythemia vera
A longer half-life means dosing every 2 weeks, instead of weekly.
Conference Coverage
Genotype, need for transfusion predict death in VEXAS syndrome
Among patients with a methionine-to-valine substitution in the UBA1 gene, survival was significantly worse, compared with patients with two other...
From the Journals
Genes related to osteosarcoma survival identified
They predict survival and are also potential therapy targets.
Conference Coverage
Rare hematologic malignancy may first present to a dermatologist
Blastic plasmacytoid dendritic cell neoplasm involves the skin in about 80% of cases.
Conference Coverage
Targeted therapies for vascular anomalies continue to be refined
The goal of future drug therapies is to support normal growth, “so we don’t need a maximum tolerated dose,” Dr. Denise Adams said.
Conference Coverage
Two treatments show early promise for hypothalamic obesity